Latest Alzheimer's Drug Discovery Foundation Stories
NEW YORK and MILAN, Italy, Dec.
New Funding From US and UK Will Facilitate "Clinical Test of Concept" NEW YORK, Dec.
NEW YORK, Sept.
Paper Addresses Challenges and Explores Opportunities to Stimulate Repurposing of FDA-Approved Drugs for Alzheimer's, Parkinson's and Related Diseases NEW YORK, June 26, 2014 /PRNewswire-USNewswire/
Expansion to Accelerate Critical Research with Goal of Bringing Novel Therapies to Patients Faster NEW YORK, June 26, 2014 /PRNewswire-USNewswire/ -- The
ADDF Harrington Scholars selected to receive funding and project management to support recent discoveries that may lead to new therapeutics for the treatment of Alzheimer's disease CLEVELAND,
Drug Could Be the First to Slow the Progression of Alzheimer's Disease NEW YORK, May 2, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's
Resource Will Provide Comprehensive Overview of the Science for Prevention Therapies NEW YORK, April 23, 2014 /PRNewswire-USNewswire/ -- The
NEW YORK, Jan. 28, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation of Canada (ADDF-Canada) and The W.
Research to Focus on Repurposing Drugs for Alzheimer's Disease and Related Dementias NEW YORK, Jan.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.